Vitamin D responsive elements within the HLA-DRB1 promoter region in sardinian multiple sclerosis associated alleles

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Cocco, Eleonora ^a   Meloni, Alessandra ^b   Murru, Maria Rita ^a   Corongiu, Daniela ^a   Tranquilli, Stefania ^a   Fadda, Elisabetta ^a   Murru, Raffaele ^a   Schirru, Lucia ^a   Secci, Maria Antonietta ^a   Costa, Gianna ^a   Asunis, Isadora ^b   Cuccu, Stefania ^a   Fenu, Giuseppe ^a   Lorefice, Lorena ^a   Carboni, Nicola ^a   Mura, Gioia ^c   Rosatelli, Maria Cristina ^a   Marrosu, Maria Giovanna ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

^c DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; HLA DRB1 ANTIGEN; RETINOID X RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HLA DRB1 GENE; HOMOZYGOTE; HUMAN; IN VITRO STUDY; MALE; METABOLITE; MULTIPLE SCLEROSIS; PROMOTER REGION; RECEPTOR BINDING; SARDINIAN; TRANSACTIVATION; VITAMIN D RESPONSIVE ELEMENT;

ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; ITALY; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; RECEPTORS, CALCITRIOL; SEQUENCE ANALYSIS, DNA; TRANSCRIPTIONAL ACTIVATION; VITAMIN D RESPONSE ELEMENT;

EID: 84864351554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041678     Document Type: Article

References (52)

1. Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, et al. (2006) McAlpine's Multiple Sclerosis, Churchill Livingstone, Philadelphia. 982 p.
2. Hauser SL, Oksenberg JR, (2006) The neurobiology of multiple sclerosis: genes, inflammation and neurodegeneration. Neuron 52: 61-76.
3. Ascherio A, Munger KL, (2007) Environmental factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61: 504-513.
4. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A, (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838.
5. Ebers GC, Sadovnick AD, (1993) The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 12: 1-5.
6. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, et al. (2005) Timing of birth and risk of multiple sclerosis: population based study. BMJ 330: 120.
7. Templer DI, Trent NH, Spencer DA, Trent A, Corgiat MD, et al. (1992) Season of birth in multiple sclerosis. Acta Neurol Scand 85: 107-109.
8. Ebers G, (2010) Month of birth and multiple sclerosis risk in Scotland. Eur Neurol 63: 41-42.
9. Staples J, Ponsonby AL, Lim L, (2010) Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ 340: c1640.
10. Lampis R, Morelli L, Congia M, Macis MD, Mulargia A, et al. (2000) The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 9: 2959-65.
11. Cocco E, Sardu C, Massa R, Mamusa E, Musu L, et al. (2011) Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 17: 1282-1289.
12. Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, et al. (2002) Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 58: 283-288.
13. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10: 2907-2916.
14. Cocco E, Sardu C, Pieroni E, Valentini M, Murru R, et al. (2012) HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia. PLoS One. 7(4):e33972. Epub 2012 Apr 11.
15. Ramagopalan SV, Ebers GC, (2008) Genes for multiple sclerosis. Lancet 371: 283-285.
16. Lampis R, Morelli L, De Virgiliis S, Congia M, Cucca F, (2000) The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from other Caucasian populations. Tissue Antigens 56: 515-521.
17. Becklund BR, Severson KS, Vang SV, DeLuca HF, (2009) UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A 107: 6418-6423.
18. Vieth R, (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856.
19. Brown AJ, Dusso A, Slatopolsky E, (1999) Vitamin D. Am J Physiol 277: 157-155.
20. Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C, Thompson PD, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349.
21. Aranda A, Pascual A, (2001) Nuclear hormon receptors and gene expression. Physiol Rev 81: 1269-1304.
22. Koszewski NJ, Malluche HH, Russell J, (2000) Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison. J Steroid Biochem Mol Biol 72: 125-132.
23. White P, Cooke N, (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11: 320-327.
24. Colnot S, Lambert M, Blin C, Thomasset M, Perret C, (1995) Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2 D3-receptor heterodimers with high affinity. Mol Cell Endocrinol 113: 89-98.
25. Maestro B, Davila N, Carmen Carranza M, Calle C, (2003) Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84: 223-230.
26. Im HJ, Craig TA, Pittelkow MR, Kumar R, (2002) Characterization of a novel hexameric repeat DNA sequence in the promoter of the immediate early gene, IEX-1, that mediates 1α25-dihydroxyvitamin D3-associated IEX-1 gene repression. Oncogene 21: 3706-3714.
27. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, et al. (2009) Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 5: e1000369.
28. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B, (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles 10.1093/nar/gkh012. Nucleic Acids Res 32: D91-94.
29. The International Multiple Sclerosis Genetics Consortium, (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
30. Munger KI, Levin LI, Hollis BW, Howard NS, Ascherio A, (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838.
31. Acheson ED, Bachrach CA, Wright FM, (1960) Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand pp. 132-147.
32. Freedman DM, Dosemeci M, Alavanja MC, (2000) Mortality to multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57: 418-421.
33. Lemire JM, Archer DC, (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87: 1103-1107.
34. Cantorna MT, Hayes CE, DeLuca HF, (1996) 1,25-Dihydroxyvitamin D3 reversibly bloks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93: 7865-7864.
35. Nashold FE, Hoag KA, Goverman J, Hayes CE, (2001) Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 119: 16-29.
36. Ebers GC, (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268-277.
37. Ohashi PS, (2003) Negative selection and autoimmunity. Curr Opin Immunol 15: 668-676.
38. Ashton-Rickardt PG, Tonegawa S, (1994) A differential avidity model for T-cell selection. Immunol Today 15: 362-366.
39. Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Muller W, et al. (1995) A role for CD25 in TCR-mediated signal transduction and thymocyte selection. Science 269: 535-537.
40. Pani G, Fischer KD, Mlinaric-Rascan I, Siminovitch KA, (1996) Signaling capability of the T cell antigen receptor is negatively regulated by PTP1C tyrosine phosphatase. J Exp Med 184: 839-857.
41. Punt JA, Havran W, Abe R, Sarin A, Singer A, (1997) T cell receptor (TCR)-induced death of immature CD4+ CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J Exp Med 186: 1911-1922.
42. Correale J, Ysrraelit MC, Gaitàn MI, (2010) Gender differences in 1,25 dihydroxyvitamin D3 immomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185: 4948-4958.
43. Soilu-Hannainen M, Laaksonen M, Laitinen I, Eralinna JP, Lilius EM, et al. (2008) A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 79: 152-157.
44. Grossman SR, Shylakther I, Karlsson EK, Byrne EH, Morales S, et al. (2010) A composite of multiple signals distinghuishes causal variants in regions of positive selection. Science 327: 883-886.
45. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Licoln MR, et al. (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 20: 1352-1360.
46. Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, et al. (2011) Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 60: 1624-1631.
47. Israni N, Goswami R, Kumar A, Rani R, (2009) Interaction of vitamin D receptor with HLA-DRB1*0301 in type 1 diabetes patients from North India. PLoS ONE 4: e8023.
48. Casu A, Pascutto C, Berardinelli L, Songini M, (2004) Type 1 diabetes among Sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999). Diabetes Care 27: 1623-1629.
49. Cucca F, Lampis R, Congia M, Angius E, Nutland S, et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their protein. Hum Mol Genet 10: 2025-2037.
50. Cossu D, Cocco E, Paccagnini D, Masala S, Ahmed N, et al. (2011) Association of mycobacterium avium subsp. Paratuberculosis with multiple sclerosis in Sardinian patients. PLoS ONE 6: e18482.
51. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69: 292-302.
52. Matilainen M, Malinen M, Saavalainen K, Carlberg C, (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1a,25-dihydroxyvitamin D3. Nucleic Acids Res 33: 5521-32.